Pharmafile Logo
Pharmafocus logo
Advanced Search

pharmaceuticals

Showing 15 posts of 68 posts found.

shutterstock_38078521

FDA awards orphan status to new brain cancer vaccine

August 9, 2017
Research and Development, Sales and Marketing FDA, life sciences, orphan drug, pharma, pharmaceuticals

The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the …

News

Merck scores expanded NICE recommendation in head, neck and oral cancer

August 8, 2017
Manufacturing and Production, Sales and Marketing Erbitux, Merck, NICE, biotech, cetuximah, drugs, life sciences, pharma, pharmaceuticals

Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …

News
nice_new_london_office_internal_3_web

NICE recommends plaque psoriasis contender for NHS use

August 8, 2017
Manufacturing and Production, Sales and Marketing Almirall, NICE< Skilarence, drugs, life sciences, medicine, pharma, pharmaceuticals, plaque psoriasis, psoriasis

The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …

News
shutterstock_311949818

Stomach acid drugs do not increase Alzheimer’s risk, study confirms

August 7, 2017
Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, biotech, drugs, healthcare, life sciences, medicines, pharma, pharmaceuticals, top ten

Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …

News
celgene_1_02

NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment

August 4, 2017
Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …

News
janssen_latest_logo_on_sign

FDA turns down Janssen’s sirukumab for rheumatoid arthritis

August 3, 2017
Sales and Marketing FDA, Janssen, drugs, life sciences, medicine, pharma, pharmaceuticals, rheumatoid arthritis, sirukumab

Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …

News
celgene_1_02

FDA approves Celgene and Agios’ acute myeloid leukaemia drug

August 2, 2017
Research and Development, Sales and Marketing Celgene, FDA, Idhifa, acute myeloid leukaemia, agios, biotech, drugs, life sciences, medicines, pharma, pharmaceuticals

The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed …

News
bha-logo

Brexit Health Alliance warns that UK/EU negotiations put patients at risk

August 1, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BioIndustry Association, Brexit Health Alliance, NHS, brexit, drugs, healthcare, life sciences, pharma, pharmaceuticals

Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …

News

Strong Q2 growth for Sanofi raises 2017 sales outlook

July 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dupixient, Sanofi, biotech, drugs, healthcare, pharma, pharmaceuticals

Sanofi exuded renewed confidence in its updated forecast for 2017 on the back of a Q2 report which illustrated strong …

News
sanofi-steve-oldfield

Department of Health appoints Teva and Sanofi veteran as commercial head

July 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, Sanofi, Teva, biotech, drugs, government, healthcare, pharma, pharmaceuticals

The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …

Appointment
cigarette_smoking

New research reveals genetic mutations in smoking-related cancers

July 27, 2017
Research and Development Cancer, biotech, drugs, health, pharma, pharmaceuticals

Researchers at the Wake Forest School of Medicine in the US have made a big discovery which could help explain …

News
janssen_latest_logo_on_sign

Janssen single tablet regimen shows Phase 3 success in HIV

July 26, 2017
Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals

The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …

News

Monthly injectable HIV treatment proves as effective as traditional daily pill regimen

July 24, 2017
Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals

New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …

News
gsk_ulverston_plant_impression

GSK continues restructure by axing £350m Cumbria plant plans

July 21, 2017
Manufacturing and Production, Medical Communications GSK, GlaxoSmithKline, UK, biotech, drugs, pharma, pharmaceuticals

Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025